Publications

Estimating annual risk of infection with Mycobacterium tuberculosis.

Dale, KD; SCHWALB, A; HOUBEN, RM G J;

2022

The Lancet Infectious Diseases, (2022).22 9 10.1016/s1473-3099(22)00452-2.

Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform.

MacKenna, B; Kennedy, NA; Mehrkar, A; Rowan, A; Galloway, J; MATTHEWMAN, J; MANSFIELD, KE; Bechman, K; Yates, M; Brown, J; SCHULTZE, A; Norton, S; Walker, AJ; Morton, CE; Harrison, D; BHASKARAN, K; RENTSCH, CT; WILLIAMSON, E; Croker, R; Bacon, S; Hickman, G; Ward, T; Davy, S; Green, A; Fisher, L; ... LANGAN, SM.

2022

The Lancet Rheumatology, (2022).4 7 10.1016/S2665-9913(22)00098-4.

Travel measures in the SARS-CoV-2 variant era need clear objectives.

KUCHARSKI, AJ; JIT, M; LOGAN, JG; COTTEN, M; CLIFFORD, S; QUILTY, BJ; RUSSELL, TW; PEELING, RW; ANTONIO, M; HEYMANN, DL;

2022

LANCET, (2022).399 10333 10.1016/S0140-6736(22)00366-X.

Know your tuberculosis epidemic-Is it time to add Mycobacterium tuberculosis immunoreactivity back into global surveillance?.

Rickman, HM; Kamchedzera, W; SCHWALB, A; Phiri, MD; Ruhwald, M; Shanaube, K; Dodd, PJ; HOUBEN, RM G J; CORBETT, EL; MacPherson, P;

2022

PLoS global public health, (2022).2 10 10.1371/journal.pgph.0001208.

Detection of HIV-1 Transmission Clusters from Dried Blood Spots within a Universal Test-and-Treat Trial in East Africa.

Pujol-Hodge, E; Salazar-Gonzalez, JF; SSEMWANGA, D; Charlebois, ED; Ayieko, J; Grant, HE; Liegler, T; ATKINS, KE; KALEEBU, P; Kamya, MR; Petersen, M; Havlir, DV; Leigh Brown, AJ;

2022

Viruses, (2022).14 8 10.3390/v14081673.

Using high-resolution contact networks to evaluate SARS-CoV-2 transmission and control in large-scale multi-day events.

PUNG, R; Firth, JA; Spurgin, LG; Singapore CruiseSafe working group,; CMMID COVID-19 working group,; Lee, VJ; KUCHARSKI, AJ;

2022

Nature Communications, (2022).13 1 10.1038/s41467-022-29522-y.

Mapping environmental suitability of Haemagogus and Sabethes spp. mosquitoes to understand sylvatic transmission risk of yellow fever virus in Brazil.

Li, SL; Acosta, AL; Hill, SC; BRADY, OJ; De Almeida, MA B; Cardoso, JD C; Hamlet, A; Mucci, LF; Telles de Deus, J; Iani, FC M; Alexander, NS; Wint, GR W; Pybus, OG; Kraemer, MU G; Faria, NR; Messina, JP;

2022

PLoS neglected tropical diseases, (2022).16 1 10.1371/journal.pntd.0010019.

Improving estimates of social contact patterns for the airborne transmission of respiratory pathogens.

MCCREESH, N; Mohlamonyane, M; Edwards, A; Olivier, S; Dikgale, K; Dayi, N; Gareta, D; Wood, R; GRANT, AD; WHITE, RG; Middelkoop, K;

2022

(2022). 10.1101/2022.02.06.22270386.

Pneumococcal vaccine schedules (PVS) study: a cluster-randomised, non-inferiority trial of an alternative versus standard schedule for pneumococcal conjugate vaccination-statistical analysis plan.

MACKENZIE, GA; Palmu, AA; Jokinen, J; OSEI, I; FLASCHE, S; GREENWOOD, B; Mulholland, K; Nguyen, C;

2022

Trials, (2022).23 1 10.1186/s13063-022-06900-x.

Vaccine efficacy trials for Crimean-Congo haemorrhagic fever: Insights from modelling different epidemiological settings.

Vesga, JF; Métras, R; Clark, MH A; Ayazi, E; Apolloni, A; Leslie, T; Msimang, V; Thompson, PN; John Edmunds, W;

2022

Vaccine, (2022).40 40 10.1016/j.vaccine.2022.08.061.